In vivo study of anticancer activity of ginsenoside Rh2-containing arginine-reduced graphene in a mouse model of breast cancer

In vivo study of anticancer activity of ginsenoside Rh2-containing arginine-reduced graphene in a mouse model of breast cancer

Objective(s): This study aims to evaluate the in vivo anticancer activity of arginine-reduced graphene (Gr-Arg) and ginsenoside Rh2-containing arginine-reduced graphene (Gr-Arg-Rh2). Materials and Methods: Thirty-two mice with breast cancer were divided into four groups and treated every three days...

Full description

Bibliographic Details
Main Authors: Shervindokht Farhangfar, Farzaneh Fesahat, Hadi Zare-Zardini, Mahdi Dehghan-Manshadi, Fateme Zare, Seyed Mohsen Mirsmaeili, Maryam Vajihinejad, Hossein Soltaninejad
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2022-12-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
arginine
breast cancer
genes
ginsenoside rh2
graphene
tumor
Online Access:https://ijbms.mums.ac.ir/article_21217_e65e14e4e4673f867b0a416cfe76a349.pdf

Internet

https://ijbms.mums.ac.ir/article_21217_e65e14e4e4673f867b0a416cfe76a349.pdf

Similar Items